General

3D Printing of Drugs

In this 90-minutes virtual event, we invite everyone to meet international world-class experts and entrepreneurs in the space of 3D printing of Drugs to showcase and update technological advances and high-value applications in this nascent and unique space. Leveraging design freedom of 3D printing and the latest research findings in pharmaceutical material science research, further optimization, and personalization medication/formulation is within arm’s reach. Don’t miss this rare opportunity to directly engage with us on this subject. Meet Aprecia, CraftHealth, FabRx, Triastek.

Speakers:

Anna Worsley

blank

Anna Worsley joined FabRx in May 2021 as a Senior Formulation Scientist. Prior to this she completed her PhD in Biomaterials for Diabetic Chronic Wounds at The Royal Veterinary College and University College London (UCL), her MSc in Nanotechnology and Regenerative Medicine from UCL, and her BSc in Anatomy and Human Biology from The University of Liverpool. During her PhD, Anna completed two internships in industry as a medical writer and R&D chemist. She also obtained a place on the Medtech Superconnector Programme, offering business training and additional funding for project continuation after her PhD. Anna hopes to use her varied experiences to support the advancement of FabRx, both with novel formulations and business growth.

Xiaoling Li

blank

Xiaoling Li, Ph.D. is a Professor of Pharmaceutics in Thomas J. Long School of Pharmacy at the University of the Pacific. Dr. Li is a Fellow of American Association of Pharmaceutical Scientists and a Fellow of American Institute for Medical and Biological Engineering. He received BS in Pharmacy and MS in Nuclear Pharmacy from Shanghai Medical University in 1982 and 1985, respectively. Under the guidance of Dr. Sung Wan Kim, Dr. Li obtained his Ph.D. in Pharmaceutics from the University of Utah in 1991. Prior to his academic career, he was a postdoctoral research fellow at Ciba-Geigy Corp (now Novartis). He served as department chair, graduate program director and Associate Dean of Graduate Education and Research during his tenure at University of the Pacific. Dr. Li’s research interest areas include oral mucosal drug delivery, novel polymers for pharmaceutical and medical application, targeting drug delivery, antibody mimics, drug transport across biological membranes, and application of physicochemical concepts to novel dosage form design. His research projects are funded by both NIH and pharmaceutical industry. He holds 18 patents with 41 patent applications pending and has published 101 papers/book chapters, over 170 abstracts/presentations, and two books entitled “Design of Controlled Release Drug Delivery Systems” and “Oral Bioavailability”. Dr. Li received CRS Outstanding Paper Award for the Journal of Controlled Release in 1992. He is a Thomas J. Long Fellow, recognized as a Distinguished Faculty Research Lecturer (2003), received Distinguished Faculty Award (2012) and Eberhardt Teacher/Scholar Award (2019) at the University of the Pacific. Dr. Li is the recipient of AAPS Outstanding Educator Award in 2015. He is a member of the Association of American Pharmaceutical Scientists, Controlled Release Society, and a convention member of USP. Dr. Li has mentored and trained 26 Ph.D., 3 MS, 16 post doctoral research fellows, and 18 visiting scientists. He co-founded two companies, Formurex, Inc., a formulation development company in 2006 and Triastek, a 3D printing pharmaceutical company in 2015. Dr. Li works closely with the pharmaceutical industry and provides consultation for product development to various pharmaceutical companies

Dr. Wei Jiang GOH

Co-Founder & Chief Executive Officer of Craft Health Pte Ltd

blank

Dr Wei Jiang GOH is currently the Co-Founder & Chief Executive Officer of Craft Health Pte Ltd, where he oversees business development and investor relations, helming the company through its fundraising rounds. Previously a National University of Singapore (NUS) Graduate School of Integrative Sciences & Engineering (NGS) PhD-MBA scholar where he earned his PhD and MBA with specialization in Finance, his research interests include formulation science and Bio-Nanotechnology. He has published more than 10 peer reviewed research articles and hold several patents. Prior to that, Wei Jiang graduated from NUS Pharmacy in 2012 and practiced as a registered pharmacist.

Tom Bradbury

Vice President, Development Engineering at Aprecia Pharmaceuticals

blank

Tom Bradbury is Vice President of Development Engineering at Aprecia Pharmaceuticals focusing on process and equipment development for Aprecia’s version of binder-jetting three-dimensional printing technology.  His 14 years at Aprecia combined with his prior experience at Therics gives him more than 25 years of industry experience with scaling and commercializing 3DP.  Tom holds MS & BS degrees in Computer Science from LaSalle University and University of Delaware, respectively.

Moderator:

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, artificial intelligence. She is an angel investor who invests in Pitch3D companies.

blank

3D Printing for Animals

According to American Pet Product Association (APPA), the current pet-related product industry is worth more than 100 billion dollars, where one-third is veterinary-related products based on 2020 data. There is a steady growth of this remarkable industry, but there are definitely more pet owners now than ever after the pandemic. Some interesting veterinary-related data can be found here

According to AVMA, Vets experienced a 50% increase in new pets per week Mar-Aug. 2020. Similar to human society, the pet market experiences similar supply chain and manufacturing challenges. Can 3D printing provide better, more efficient veterinary care and a more robust supply chain than the traditional way of things?

Speakers:

Matteo Zanfabro

blank

Matteo Zanfabro, Doctor of Veterinary Medicine, is applying 3D printing to Veterinary  Medicine since 2015 during his experimental thesis “The use of 3D printing in pre operative surgical planning”. After graduation in 2017, he founded a private research project named “3D Veterinary Printing” which focused on veterinary clinical research and application of 3D printing technology, winning the “MSD Community Award” in 2018.  After a period as a Research Fellow at the University of Parma, now he is full-employed in PlayCast (www.playcast.it) as a member of R&D and in charge of the new company branch: PlayVet (www.playvet.it). It is a system for Veterinary Hospital and Clinics to  provide 3D printed made-to-measure veterinary medical devices for small animal patients, from orthosis to perioperative supports. PlayVet is going to be available from  September 2021 in few authorized centers in northern Italy.

Dr. Johnny Uday

Veterinarian, 3D biomodeler, 3D researcher

blank

Owner of AXIS 3D MEDICAL PRINTING

With special interest in providing affordable personalized solutions for people/animals in developing countries.

First Place in the “International Congress of Maxillofacial Surgery and Oral Rehabilitation Ecuador 2019”

With the conference “Use of 3D Open Source Software in Maxillofacial Surgery and Reconstruction”

First place in the “Inter Hospital Case Report Contest Ecuador 2021”

With the case “ Personalized Total Joint Replacement for a teenager with Ameloblastoma of the Jaw”

Speaker in several National and International Congresses

Patents:

3D printed device for Atlanto Axial subluxation

3D printed device for transdermal weight- bearing prosthesis

Optimized temporomandibular joint interface with 3D printing and CNC machining

Mateusz Pawlik

Mateusz Pawlik

Graduate of Biomedical Engineering at the Silesian University of Technology in Poland.  He gained his experience working in international companies in the medical industry as a product engineer and continuous development manager.  Co-owner of CABIOMEDE – company providing R&D services in medical engineering area and Pets Analytics – startup developing an innovative solution in the field of animal health monitoring.

Operations Manager responsible for new products and technology development – presurgical models, custom made surgical guides and implants, polymeric and metal spine and joint implants for animals. Together with CABIOMEDE team developed more than 500 patient’s cases on a basis of Computed Tomography. His biggest project was related to create veterinary surgical workshop models – full canine and feline fractures database according to AOVet classification.

Alexander Tholl

blank

Alex is co-founder and CEO of DiveDesign a product design and development firm based out of NYC/NJ. Alex started his design career in freelance and then moving into the As Seen On TV product market. With a desire for better processes and design, he teamed up with a close college friend to build DiveDesign. Dive helps its clients strategically develop new and innovative products through deep market research, design conceptualization, prototyping, and traditional/alternative manufacturing methods. As Dive has grown, Alex and Adam have honed in on helping large companies tell compelling stories through product development for all types of marketing purposes. You can find us @divedesignco on Facebook/Instagram and TikTok.

blank

3DHEALS Startup Showcase: Singapore

3DHEALS is returning to Singapore once again to co-host an exciting start-up showcase event with NAMIC to connect local business leaders, innovation enthusiasts, investors, and entrepreneurs in the healthcare 3D printing, bioprinting, and medical technologies space. This showcase event is a premier opportunity to hear directly from founding team members to learn more about the thriving Singaporean start-up ecosystem as they strive towards shaping the future of patient care. In the lead up to the event, gain a deeper understanding of the contributing factors to Singapore’s start-up success through our in-depth guide found here.

Speakers:

Ben Holmes

CEO and Co-Founder of Nanochon

blank

Dr. Ben Holmes is an entrepreneur, medtech executive, inventor and scientist. He is the founder of Nanochon, which is commercializing a 3D printed implant for regenerating lost or damaged cartilage in joints. His academic background is in 3D printing and biomaterials for tissue engineering and regeneration.

Adam Jakus

Co-Founder and Chief Technology Officer of Dimension Inx

ADAM E. JAKUS, PH.D.

Dr. Adam Jakus is Co-Founder and Chief Technology Officer of Dimension Inx, a Chicago-based, advanced biomaterials and biofabrication company. As CTO, Adam leads Dimension Inx internal innovation, external collaborative projects, as well as manufacturing activities. For the past 11 years, Adam has been intimately involved with advanced, functional material design for 3D-printing and bioprinting, covering and developing new 3D-printable materials as diverse as metals and alloys, ceramics, graphene and nanotubes, extraterrestrial regoliths, gels, and advanced hard and soft tissue regenerative biomaterials – encompassing a materials-centric platform now collectively referred to 3D-Painting. With a Ph.D. in Materials Science and Engineering from Northwestern University and B.S. and M.S. degrees in Materials Science and Engineering from Georgia Tech, Adam is a Materials Engineer at heart and believes the future of medical and non-medical technologies lies in the development of new, advanced materials.

Chia Lye Peng

Co-Founder and CEO of FlexoSense

blank

Lye Peng has more than 25 years of multi-faceted Asia Pacific and global experiences in the MNC and SME environment; including technology licensing, business development, sales and marketing, e-commerce, learning & development and operations. Her intrapreneurial & enterprising skills have had provided opportunities in ground-breaking stretch goals initiatives, in collaboration with global colleagues across diverse cultures, perspectives and domain expertise. She brings these experiences and skillsets to FlexoSense as a co-founder & CEO where she hopes the Singapore-based company can create a global impact under UN Sustainable Development Goal (SDG) #3, Good Health and Well-Being. Encouraging a growth mindset, she is ever ready to champion bold ideas from colleagues that dovetail with this SDG #3. Having a family history of diabetes, the first area of impact the company hopes to make a difference is in the global diabetes problem.

Amrish Nair

Co-Founder and CEO of Biorithm

blank

Born and raised in Singapore, Amrish Nair received his B.Eng. and M.Eng. from the School of Electrical and Electronic Engineering at the Nanyang Technological University. His graduate studies research led him to numerous international publications and a US Patent on ECG signal analysis and monitoring. His research collaboration with TTSH cardiologist, Dr. David FOO and NTU supervisor Assoc. Prof. Pina Marziliano led him to spin-off BIORITHM, a medtech startup providing cutting-edge signal processing solutions in the fields of remote monitoring and wearable technology. Amrish Nair is passionate in developing medical device technologies for the well-being and health of patients. As one of the founding members of BIORITHM, Amrish and his team set out with the aim of making medical technology more affordable and available whilst pushing technological limits to greater progression.

Dr. Wei Jiang GOH

Co-Founder & Chief Executive Officer of Craft Health Pte Ltd

blank

Dr Wei Jiang GOH is currently the Co-Founder & Chief Executive Officer of Craft Health Pte Ltd, where he oversees business development and investor relations, helming the company through its fundraising rounds. Previously a National University of Singapore (NUS) Graduate School of Integrative Sciences & Engineering (NGS) PhD-MBA scholar where he earned his PhD and MBA with specialization in Finance, his research interests include formulation science and Bio-Nanotechnology. He has published more than 10 peer reviewed research articles and hold several patents. Prior to that, Wei Jiang graduated from NUS Pharmacy in 2012 and practiced as a registered pharmacist.

Prof. Huang Dejian

Co-Founder of Kosmode Health Singapore Pte Ltd

blank

Dejian was trained as a chemist with a PhD degree (1999) in inorganic chemistry from Indiana University and postdoctoral research experience (Chem Eng) from Massachusetts Institute of Technology. He began his independent research career in 2001 by venturing into the chemistry of food bioactive constituents for health promotion and disease prevention and plant proteins. Specifically: 

  • Chemistry of bioactive compounds in fruits and vegetables for controlling diabetes, anti-aging, antioxidants, anti-inflammation, anti-obesity 
  • Plant proteins for 3D printing of seafood mimics and scaffolds for cell-based meat culture and biomedical applications 

He has published over ~200 papers and was named by Thomson Reuters as a Highly Cited Researcher 2014 and 2015. Dejian is an associate editor of Journal of Functional Foods, and Frontiers in Nutrition Food Chem. He is a co-founder of Kosmode Health Singapore Pte Ltd (2016) (https://kosmodehealth.com/).

Mike Graffeo

CEO and Co-Founder of Fluidform 3D

blank

In over 20 years in the life sciences, Mike has brought four novel products through the FDA that have generated over $20 billion in sales in both startup and growth organizations. Throughout his career, he has worked on the forefront of medical technologies, translating highly complex products and clinical data into successful businesses, both in the US and around the world.

Timothy Chua

Digital Transformation Strategy and Biz Dev, HP Inc.

blank

“I am an amicable young multipotentialite who is eager to learn about everything and hence I always ask many questions. I have a strong desire to contribute towards Singapore’s transition from a linear economy to a circular one and truly believe that this is possible here through a combination of design, reverse logistics and regulation. I envision myself gaining industry experience in my early career before moving onto consultancy work, followed by policy making and finally educating the next generation in my late years.”

Dr. Ho Chaw Sing

Managing Director of NAMIC

blank

Dr Ho Chaw Sing is the co-founder Managing Director of NAMIC (National Additive Manufacturing Innovation Cluster), a Singapore government platform initiative to catalyse innovation and scale industrial adoption of digital additive manufacturing technologies. Since its inception in 2015, NAMIC has raised millions in public-private funding to catalyse various AM initiatives across several industry sectors. Before joining the public sector, he spent several years with HP Singapore and Chartered Semiconductor, where he undertook various executive roles in technology and product development, as well as supply chain and business operations. A technology-for-good advocate, Chaw Sing has been active in scouting and nurturing AM deep tech start-ups, contributing to the growing startup ecosystem in Singapore. Chaw Sing is the co-chair of the Singapore Standards AM Technical Committee, and sits in the ASTM International AM Centre of Excellence (AM CoE) Steering Committee. Chaw Sing earned his doctorate (Ph.D) in Electrical and Computer Engineering and Bachelor’s (honours) degree in Electrical Engineering with a major in Microelectronics from the National University of Singapore, where he is currently an adjunct Professor.

Moderators:

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, founder/CEO of 3DHEALS. Her main interests include medical education, 3D printing in the healthcare sector, and artificial intelligence. She is also a current adjunct clinical faculty in the radiology department at Stanford Healthcare.

Mahendran V. Reddy

Mahendran Reddy

Mahendran Reddy is a highly driven professional with 20 years of international professional experience in the creative industries in both the private and public sectors.

As a trained architect and a media personality, he has held key strategic appointments in driving innovation and initiatives in the civil service, notably the establishment of the National Design Centre in Singapore.

At UCT, he has driven the adoption of Additive Manufacturing in its fledgling form in South East Asia mainly in the consumer segment of the business.

At NAMIC, he is actively involved in the adoption of Additive Manufacturing in the Industries by initiating collaborative research projects with Industry and Institutes of Higher Learning.

He brings with him an in-depth knowledge in management, government processes and procurement, design thinking skills and excellent interpersonal and professional competencies.

blank

Dental 3D Printing: Latest in Digital Dentistry

Dentistry seems to be the potential breakthrough industry to manifest many 3D printing enthusiasts’ dream of mass customization, point of care delivery, and local manufacturing hub for dental professionals, reducing inefficiency and costs. Over the past several years, 3DHEALS has invited many different stakeholders to share their experiences, ranging from material innovation, software development, to new clinical workflows. Applications ranging from surgical guides, implants, dentures, night guards are among the new applications gaining increasing attention either in the startup world or the industry at large, in addition to the existing billion dollar market of dental aligners. The collective thought is that 3D printing can do more and more in parallel to the maturation of technologies. 

Speakers:

Justin Marks

blank

Justin Marks, CDT is the Founder and CEO of Arfona Printing, a leader in 3D printing technologies for dental prosthetics. An accomplished dental technician, educator and lab owner, Justin has lectured and taught courses on digital dentistry and removable prosthodontics in more than 40 countries. Since 2008 Justin has dedicated the majority of his career to applying computer aided design and 3D printing technologies to removable prosthodontics and is credited with the invention of the world’s first 3D printed flexible partial denture. Justin holds his board certification as a dental technician in the complete and partial denture specialties and graduated Summa Cum Laude from Pace University with a BBA in marketing and management.

Rick Ferguson DDMD

blank

Dr. Ferguson has been involved in teaching implant dentistry for the last 20 years and has lectured in every major city in the United States as well as internationally. These lecture topics have included treatment planning, case selection, simple and complex surgical placement and restoration, advanced bone grafting and bone graft materials, use of Computed Tomography and surgical guides, management of complications and failures. Dr. Ferguson has placed and restored over 5000 dental implants and maintains a private practice with his wife Dr. Katherine Ferguson in Davie, FL emphasizing dental implants and where they also teach a live surgery course. Dr. Ferguson has been instrumental in implementing implant training programs and hands on bone grafting courses which have been attended by thousands of dentists. More recently Dr. Ferguson has pursued the use of 3D printing to benefit the clinical dental practice and created the Dental 3D printing Facebook group which has almost 15,000 members wordlwide.

Mayra Vasques

blank

Dr. Mayra Vasques is researcher at Univ. of Sao Paulo (Brazil) and founder of iNNOV3D an EdTech company focused on supporting and training teachers and universities for the innovative and efficient use of 3D Technologies in Dentistry. She started in the additive manufacturing field in 2015, during her PhD Fellow at School of Dentistry at the University of Sao Paulo, where she led a project in additive manufacturing for the development of occlusal splints for patients with orofacial pain. Since then, she has published scientific papers and she has been involved in several AM research projects and as panelist in conferences. She is deeply involved in creating a positive and accessible local ecosystem in Brazil for digital technology and AM, working for to build the local community as Latin America Chair at ”Women in 3D Printing” company and Community Manager at “3DHeals”.

Lee Dockstader

blank

Lee Dockstader is engaging with companies to grow additive manufacturing across medical and dental verticals with an emphasis on orthopedic and prosthetic production applications for HP’s Multi Jet Fusion 3D printing technology. Before HP, Lee held several positions during his 18-year career at 3D Systems including VP of Business Development, VP and General Manager of the Stereolithography Products Business Unit and VP and GM of the Asia Pacific region. Before 3D Systems, Lee worked for three years at 3D/EYE Inc, a leading-edge 3D software company as sales and distribution manager. For 11 years he held a variety of sales and marketing positions at Hewlett-Packard. During this period, Lee spent three years as program manager for HP’s Asia mechanical engineering CAD business, based in Hong Kong. Lee attended the West Point Military Academy and received a Bachelor of Science degree in Engineering from UCLA.

SĂ©rgio Luis Rodrigues Gianvechio

Dentist at CROIB ODONTOLOGIA

blank

Graduação em Odontologia Universidade de Uberaba/MG (1998). Especialização em Endodontia pela APCD Araraquara/SP (1999). Especialização em Ortodontia IPESP (2008). Invisalgn Doctor – 2009. Desenvolvedor de fluxos digitais em softwares livres para Ortodontia. Ministrador de cursos de Odontologia Digital no Brasil e Exterior (College of Dentistry – University of Florida). CEO da clínica CROIB Odontologia

blank

3D Printing in Hospitals

In recent years, many hospitals have started making a shift, from using medical images primarily for diagnostic purposes, to integrating them in patient-specific surgical planning. This has created enormous advantages for hospitals and their patients and is largely supported by the clarifying regulatory landscape, increased governmental support, new public and private initiatives, and the expanding role of the radiologist as an imaging expert. As part of this, an increasing number of hospitals across the world have integrated the practice of 3D printing into their medical care. Hospitals are recognizing the added value it brings to personalized patient care and the countless possibilities that are becoming a reality, in creating better treatment options.

Speakers:

Kerim Genc

blank

Kerim Genc is the Business Development Manager for the Simpleware Product Group at Synopsys.  He joined Simpleware in 2011 and is currently responsible for managing global sales, business development, partnerships and technical marketing content development, with a significant focus on image-based patient specific workflows for 3D Printing and surgical guides/planning.  He received his BS and MS in biomechanics from the University of Calgary and the Pennsylvania State University respectively, and completed his PhD in Biomedical Engineering at Case Western Reserve University, examining countermeasures to and computational models of spaceflight induced bone loss and fracture risk.

Shannon Walters

blank

Shannon Walters is an innovation enabler and workflow-optimization enthusiast. At Stanford 3D and Quantitative Imaging Lab, Shannon works closely with healthcare providers, researchers, and educators to enable effective health visualization. 

Recent innovations are of particular interest to Shannon such as 3D Printing, immersive volumetric visualization, and concise reporting of changes over time. 

Paul Fotheringham

blank

Paul Fotheringham is the founder of 3D LifePrints (3DLP) and is an experienced Technologist, Entrepreneur, and 3D printing expert who focuses on the medical sector. He holds a joint Bachelor of Science degree in Computer & Management Science from the University of Edinburgh. After graduating, he worked in over 10 countries including the US, UK, HK, Japan, and South Korea as an Enterprise Architect for organizations such as the London Stock Exchange, British Petroleum, Accenture and Macquarie Group. In 2012 he took up a post as Chief Technology Officer for a global Micro-finance organization in Kenya where he subsequently started 3DLP initially as a Social Enterprise in order to provide sustainable, affordable and suitable 3D printed prosthetics for developing world amputees. He currently overseas 3DLP’s European operations from Barcelona that provide a variety of innovative medical 3D printing products and services to medical institutions.

Albert Woo

blank

Albert S. Woo, MD, FACS is a board-certified plastic and reconstructive surgeon specializing in craniofacial surgery. This work has led to a particular interest in three dimensional imaging and printing of complex surgical models. He is an Associate Professor of Surgery, Pediatrics and Neurosurgery at The Warren Alpert Medical School of Brown University and serves as the Chief of the Division of Pediatric Plastic Surgery, Director of the Cleft and Craniofacial Center at Hasbro Children’s Hospital, and is the founding Director of the Lifespan 3D Printing Laboratory.

blank

Microfluidics, Technology, Commercialization

“Microfluidics refers to the behavior, precise control, and manipulation of fluids that are geometrically constrained to a small scale (typically sub-millimeter) at which surface forces dominate volumetric forces. It is a multidisciplinary field that involves engineering, physics, chemistry, biochemistry, nanotechnology, and biotechnology. It has practical applications in the design of systems that process low volumes of fluids to achieve multiplexing, automation, and high-throughput screening. Similar to 3D printing, microfluidics emerged at the beginning of the 1980s and is used in the development of inkjet printheads, DNA chipslab-on-a-chip technology, micro-propulsion, and micro-thermal technologies, organ-on-a-chip, and more. 3D printing has been both a manufacturing method and an application for microfluidics. 

Speakers:

Albert Folch

blank

Albert Folch received his BSc in physics from the University of Barcelona (UB), Spain, in 1989. In 1994, he received his Ph.D. in surface science and nanotechnology from the UB’s Physics Dept. During his Ph.D. he was a visiting scientist from 1990–91 at the Lawrence Berkeley Lab working on AFM under Dr. Miquel Salmeron. From 1994–1996, he was a postdoc at MIT developing MEMS under the advice of Martin Schmidt (EECS) and Mark Wrighton (Chemistry). In 1997, he joined the laboratory of Mehmet Toner as a postdoc at Harvard’s Center for Engineering in Medicine to apply soft lithographic methods to tissue engineering. He has been at Seattle’s UW BioE since June 2000 where he is now a full Professor, accumulating over 6,700 citations (averaging >82 citations/paper over his whole career). His lab works at the interface between microfluidics, cancer, and neurobiology. In 2001 he received an NSF Career Award and in 2014 he was elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows (Class of 2015). He serves on the Advisory Board of Lab on a Chip since 2006. Albert Folch is the author of four books, including “Introduction to BioMEMS”, a textbook now adopted by more than 77 departments in 17 countries (including 40 universities in the U.S. alone). Since 2007, the lab runs a celebrated outreach art program called BAIT (Bringing Art Into Technology) which has produced seven exhibits, a popular resource gallery of >2,000 free images related to microfluidics and microfabrication, and a YouTube channel that plays microfluidic videos with music which accumulates ~133,000 visits since 2009.

Mohsen Akbari

Mechanical Engineering, University of Victoria

blank

Dr. Mohsen Akbari is an Associate Professor of Mechanical Engineering and the Director of the Laboratory for Innovations in Microengineering (LiME) at the University of Victoria. In addition to his professorship, he is a member of the Center for Advanced Materials and Related Technologies (CAMTEC), member of Center for Biomedical Research (CBR), investigator at International Collaboration on Repair Discoveries (ICORD), Associate Member of Djavad Mowafaghian Centre for Brain Health and the co-founder and Chief Scientific Officer at 4M Biotech. Dr. Akbari obtained his Ph.D. from Simon Fraser University and his postdoctoral training at Harvard Medical School and Brigham and Women’s Hospital. He is the recipient of several awards, including the NSERC Postdoctoral Fellowship Award, Michael Smith Foundation Idea to Commercialization Awards, BC Innovation Council Research Award, Kaiser Foundation Award, and recognized as a Canadian Rising Star in Global Health by Grand Challenges Canada. Dr. Akbari’s research lies at the interface of cellular biology, biomaterials, and microtechnologies and aims to develop innovative approaches for disease modelling and drug delivery. He currently holds funding from CIHR, NSERC, CFI, BC Cancer Foundation, and the Department of National Defense. He is a Guest Editor of Micromachines and Gels and a member of the Board of Directors of the Canadian Society for Mechanical Engineering. His research findings have been published in 90 peer-reviewed journal papers and book chapters with an h-index of 35 and over 5300 citations. His work has been featured on the cover of 11 Journals and reported in media such as CBC News, Time Colonist, BBC News, Google News, Science Daily, The Telegraph, and Fortune.

Nick Allan

blank

Nick Allan is the Bio Services Manager at StarFish Medical. Allan joined the company as a Project Manager, becoming Bio Service Manager in 2016. He has provided innovative solutions to client issues ranging from proof-of-concept studies for rapid detection point of care assays to full-scale regulatory submission studies, and designed and facilitated more than 500 Unique Research Protocols. Allan is President of Chinook Contract Research, co-founder and former GM of The Institute for Applied Poultry Technologies, and former Contract Research Manager at Innovotech Inc. Allan holds an MS in Microbiology and BS in Biology from the University of Guelph.

Simon Beyer

blank

Simon is the Chief Technology Officer at Aspect and oversees the advancement of our biomanufacturing technologies. He leads our engineering teams and the development of our core technologies, including bioprinting systems, microfluidic printheads, biomanufacturing automation, tissue design software, and machine learning. Simon is a principal inventor of Aspect’s microfluidic bioprinting technology with broad expertise developing advanced printing systems for applications including printed electronics, self-assembling nanomaterials, and biological tissue.

Simon holds a B.A.Sc. and M.A.Sc. in Electrical Engineering from the University of British Columbia

Moderator:

Kate Clancy

blank

Kate Clancy is a Research Associate at Angle Biosciences Inc.(ABI) and a 3DHEALS Community Manager. At ABI, she works on both engineering and surface coating projects to design fluidic devices. Kate holds a MEng in Biomedical Engineering from McGill University and BSc in Biochemistry from the University of Guelph.

blank

3D Bioprinting for Food

Lately, 3D printing food has become a hot topic, as climate change and the impending water shortage crisis all beckon humanity for alternative more environmental (and healthier) food sources. “Cultured meat”, “cellular agriculture”, “lab-grown meats” are all new popular concepts that are receiving increasing attention. What are the roles of 3D printing in all this? What are the issues entrepreneurs and scientists facing? Who are the influencers, rising startups, regulatory bodies for this emerging field? How is the culinary world receiving the 3D printing concept? 

Speakers:

Avery Parkinson

blank

Avery is the Executive Director of Cellular Agriculture Canada. She has been passionate about cell ag technology for a couple of years now and has held positions at Tufts University, Big Idea Ventures, the Good Food Institute, and the Protein Report where she has worked on creating educational content and resources to grow the industry nationally and worldwide.

Kyle Von Hasseln

blank

Kyle von Hasseln is an American inventor, entrepreneur and adventurer. He graduated Middlebury College with a focus in molecular ecology. He was awarded the Frank Gehry Prize for Best Thesis at the Southern California Institute of Architecture, where he invented and patented the first dehydrated food 3D printer. His startup, Sugar Lab, was acquired by 3D Systems where he led the development of the first NSF certified commercial food 3D printer. In 2020 he founded Culinary Printworks, the first on-demand culinary 3D printing firm, and brought back the retail Sugar Lab brand. Kyle is an avid backcountry skier, surfer, and alpine rock climber.

Roger Kuan

blank

Roger Kuan is a Partner at Haynes and Boone and chair of the Precision Medicine and Digital Health Practice Group, where he counsels companies that are uniquely positioned in the convergence of the life/medical sciences and technology industries on how to successfully navigate the complexities of the intellectual property (IP), data rights and regulatory challenges they encounter.Roger has extensive experience in IP strategy and portfolio management (utility/design patents, trademarks, copyrights, and trade dress), data rights strategy, licensing and technology transactions, freedom-to-operate clearances, enforcement, monetization, IP due diligence, and dispute resolution. His practice is focused in the life sciences sector (e.g., research tools, analytical instrumentation/software, digital therapeutics, medical devices, diagnostics, biomanufacturing equipment, etc.) with an emphasis in emerging technologies such as Precision Medicine (e.g., genomic sequencing platforms, AI/ML, computational genomics/bioinformatics, molecular diagnostics, companion diagnostics, etc.), Digital Health (e.g., mobile apps, clinical decision support, software, digital therapeutics, AI/ML Imaging Diagnostics, wearables, etc.) and 3D printing/bioprinting. Prior to joining Haynes and Boone, Roger served as Director, IP Counsel at a multinational biotechnology company, where he managed a team to support the worldwide IP needs of the company’s life sciences tools, bioproduction/biomanufacturing, molecular diagnostics, and nucleic acid sequencing system/software platforms. Prior to finishing his law degree, he worked in the life sciences industry for several Fortune 500 pharmaceutical, medical device, and chemical companies. He has held professional positions in the R&D, sales, engineering, and regulatory affairs organizations.

Simon Fried

blank

Simon, head of business at MeaTech, grew up around restaurants, has business experience including food retail, FMCG, distilleries and 3D printing. Combined with his academic background in risk, behavioral economics, and behavior change, he’s excited to be playing a part in the cultivated meat transformation.

Moderator:

Dr. Vidya Chamundeswari Narasimhan

 3DHeals Community Manager – San Francisco

blank

Dr. Vidya is currently heading the Biomaterials engineering division at NEW AGE MEATS – Berkeley, California. She received her Ph.D from Nanyang Technological University(NTU), Singapore in 2018. Her research focused on developing bioactive polymeric scaffolds for musculoskeletal tissue regeneration applications.

During her post doctoral fellowship in Singapore, Vidya spearheaded various academia-industrial collaborative projects. At 3DHEALS, she is our Community Manager of San Francisco Bay Area and is also actively involved in STEM mentorship and in tutoring University and Junior college students for various competitive examinations.  

Vidya has been actively involved in research pertaining to sustainability within the agro-food and biomaterials sector, and is passionate about emerging technologies in the field of 3D bioprinting. She hopes to actively share and spread this interest amongst like minded professionals in the field of  regenerative medicine and tissue engineering. Currently Vidya has contributed to a couple of expert column blogs on bone tissue engineering and is the co-instructor of an online course on Bioinks used for Bioprinting available on Udemy!

blank

3D Printing in Orthopedics

In this virtual event focusing on 3D printing in Orthopedics, we feature a panel of international influencers, rising startups, and hot topics to both learn and discuss what innovators and entrepreneurs are experiencing from their personal perspectives, ranging from metal 3D printing, implants, to various other 3D technologies that are related to 3D printing surgical planning tools, such as AR/VR/MR. Through the conversation, we hope to learn more about current industry landscape and trends.

Speakers:

Dr. Alan Dang

blank

Dr. Alan Dang is a board-certified, licensed orthopaedic spine surgeon. He is an HS Clinical Associate Professor at UCSF. Along with his brother, Dr. Alexis Dang, he started the Orthopaedic Rapid Intelligent Fabrication (ORIF) program at UCSF/San Francisco VA and is a founding member of the UCSF Center for Applied 3D+ Technologies. Dr. Dang is also a capstone mentor and member of the selection committee for the UCSF/UC Berkeley Masters in Translational Medicine program.

Brian McLaughlin

blank

Brian is the founder of Amplify Additive. He is passionate about orthopedics and is well-versed in all aspects of advanced manufacturing – from the industry’s leading innovators and product development to commercialization strategies and business trends. Creative and entrepreneurial by nature, Brian’s attention is on identifying opportunities for new business development in existing and emerging orthopedic markets, and in assisting companies looking to leverage AM technology.

Brian and his team at Amplify are focused on advancing Additive Manufacturing for Orthopedics, utilizing GE Additive’s Arcam Electron Beam Melting (EBM) technology for innovative implant solutions across all indications. Brian has experience across all industry lines in the orthopedic market including design & manufacturing for a leading CMO; as a clinical specialist working directly with surgeons; as the VP of Engineering and co-founder of a Foot & Ankle implant company leveraging AM for implants; and now as the leader at Amplify Additive.  Brian has a BS in Biomedical Engineering from the University of Vermont.  

Brian lives in Yarmouth, ME with his wife and two sons. In addition to his passion for the orthopedic market, he enjoys playing and coaching soccer, alpine skiing, cycling, running and occasionally golfing.

Interview with Dr. Alan Dang, co-Founder of PrinterPrezz

Dr. Bruno Gobbato

blank

Dr. Gobbato is an orthopedic surgeon and specialist in the anatomy of shoulders and elbows. He has been a part of 3D printing in medicine and orthopedic models since 2013. Works with mixed reality and Artificial Intelligence. 

Interview with Dr. Bruno Gobbato: 3D Printing Orthopedics

Dr. Richard Hurley

blank

Dr. Richard Hurley is an orthopaedic surgeon with over a decade of experience in medical 3D printing. He is an assistant professor at Dalhousie University in Halifax, Nova Scotia specialising in hip and knee replacement surgery. In 2012 he co-founded Conceptualiz to provide easy to use virtual surgical planning and medical 3D printing software to healthcare providers. He is the director of the in-hospital medical 3D printing lab at the Dartmouth General Hospital. He is also the curator of the 3D Orthopaedic Special Interest Group (3DOS) and was a former computer assisted surgery product manager for DePuy Canada.

Moderator:

Dr. Nathan J. Castro

blank

Dr. Nathan J. Castro is an experienced biomedical researcher and entrepreneur.  He has assisted in the design, testing, regulatory approval and clinical translation of 3D printed medical devices, as well as co-founded Nanochon, Inc.  He is skilled in policy analysis, life sciences, data analysis, and quantitative research with particular interest in clinical translational (bench-to-bedside).  With domestic and international research appointments at well-recognized laboratories, Dr. Castro is always in search of opportunities to leave a positive impact on whomever he has the pleasure of working with.

blank

The Legal Landscape in Healthcare 3D Printing

It is our experience that risk can be mitigated with knowledge. In the upcoming months, we plan to invite legal and regulatory experts to provide foundation knowledge and updates on the legal landscape in healthcare 3D printing. These webinars will focus on critical issues faced by entrepreneurs and startups in the healthcare 3D printing ecosystem, ranging from intellectual property, medical device liability, as well as FDA and CE regulations and guidance, focusing both on biological and non biological devices.

Speakers:

Sean Burke

Sean Burke profile

Sean Burke is partner and vice chair of the products liability trial division at Duane Morris. He is in the firm’s Washington, DC office.  Mr. Burke’s practice focuses on representation of manufacturers of medical devices in products liability cases across the country, including in consolidated multi-plaintiff matters in both federal court and state courts. His experience includes defense of large total joint replacements (hips, knees, ankles, and shoulders) and resurfacings, tissue matrices and patches, fusion plates, and surgical instruments.  He has a particular interest and focus on additive manufacturing, consulting and advising clients on best practices in the early stages of development to reduce risk of products liability exposure.  He has tried medical device cases before juries in both state and federal courts while also handling numerous mediations.  He works closely with scientific experts to advance causation and liability defenses in the areas of biomechanical engineering, toxicology, histology, epidemiology, orthopedic surgery and FDA regulations.

Roger Kuan

blank

Roger Kuan is a Partner at Haynes and Boone and chair of the Precision Medicine and Digital Health Practice Group, where he counsels companies that are uniquely positioned in the convergence of the life/medical sciences and technology industries on how to successfully navigate the complexities of the intellectual property (IP), data rights and regulatory challenges they encounter.Roger has extensive experience in IP strategy and portfolio management (utility/design patents, trademarks, copyrights, and trade dress), data rights strategy, licensing and technology transactions, freedom-to-operate clearances, enforcement, monetization, IP due diligence, and dispute resolution. His practice is focused in the life sciences sector (e.g., research tools, analytical instrumentation/software, digital therapeutics, medical devices, diagnostics, biomanufacturing equipment, etc.) with an emphasis in emerging technologies such as Precision Medicine (e.g., genomic sequencing platforms, AI/ML, computational genomics/bioinformatics, molecular diagnostics, companion diagnostics, etc.), Digital Health (e.g., mobile apps, clinical decision support, software, digital therapeutics, AI/ML Imaging Diagnostics, wearables, etc.) and 3D printing/bioprinting. Prior to joining Haynes and Boone, Roger served as Director, IP Counsel at a multinational biotechnology company, where he managed a team to support the worldwide IP needs of the company’s life sciences tools, bioproduction/biomanufacturing, molecular diagnostics, and nucleic acid sequencing system/software platforms. Prior to finishing his law degree, he worked in the life sciences industry for several Fortune 500 pharmaceutical, medical device, and chemical companies. He has held professional positions in the R&D, sales, engineering, and regulatory affairs organizations.

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, founder/CEO of 3DHEALS. Her main interests include medical education, 3D printing in the healthcare sector, and artificial intelligence. She is also a current adjunct clinical faculty in the radiology department at Stanford Healthcare.